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Reply
We would like to thank Drs. Guntheroth and Parras for their
interest in our study, which underlined that the assessment of
aortic stenosis (AS) severity should integrate the flow-gradient
pattern to the classic measurement of aortic valve area (1). The
eason is that most of the echocardiographic parameters used to
ssess the severity of AS are flow dependent. As a general rule, a
ow transvalvular gradient (40 mmHg) or velocity (4 m/s) does
ot exclude the presence of a severe AS in patients with small
ortic valve areas and preserved left ventricular (LV) ejection
raction. In addition, a preserved LV ejection fraction (50%)
oes not exclude the presence of myocardial systolic dysfunction
nd low transvalvular flow in AS. Such rules are also applicable to
ongenital AS, particularly when concomitant aortic regurgitation
xists (2).
In daily practice, the discrepancy between gradient and aortic
alve area may potentially lead to an underestimation of AS and
ymptom severity and therefore to an inappropriate delay of aortic
alve replacement (AVR). Unless related to concomitant valvular
mitral or aortic) regurgitation, potential causes for these
iscordances include: 1) measurement errors; 2) small body size;
) paradoxical low-flow AS; and 4) inconsistent grading related to
ntrinsic discrepancies in guideline criteria. As a first step, the best
ule of the thumb is to confirm the low-flow state using volumetric
pproaches (2- or 3-dimensional echocardiography). If the stroke
olume measured by these independent methods is consistent with
he stroke volume measured using the LV outflow tract, one can be
eassured of the accuracy of the measurement of stroke volume.
uch a low-flow state represents a witness of intrinsic myocardial
ysfunction and a more advanced disease process. It could be
ssociated with either high-gradient or low-gradient AS.
In our study, all patients were regularly followed in our
utpatient heart valve clinic. Both soft and hard events were
onsidered in a composite end point defined as cardiovascular
eath or need for AVR motivated by the development of symp-
oms or LV dysfunction. This eliminates bias related to the
nclusion of AVR not dictated by symptoms. As mentioned by Dr.
arras, there are some discrepancies in the hazard ratios reported
n the “Results” section of the report and in Table 4 [1].
evertheless, these differences did not affect the interpretation ofthe results. In fact, such differences are explained by different
multivariate models used in the 2 sections. According to the
statistical review, it was suggested, to avoid overfitting of the
models, not to include variables with high degrees of colinearity.
These changes were reported in Table 4 [1], but not in the text, in
which the multivariate model including all variables was provided.
Peak aortic velocity and mean aortic gradient are closely and
directly correlated. Therefore, it may be difficult to admit that
those variables predict events in a contradictory fashion. However,
this reflects the statistical models used. The normal-flow low-
gradient entity represented the referent group. This is the reason
why the peak aortic velocity or the low-flow pattern predicted the
outcome compared with the referent group. However, outcome
prediction was more significant in the low-flow low-gradient
entity. These results were obtained even if the incidence of the
low-flow low-gradient AS pattern was low. Of note, 82% of
patients in this category experienced cardiac events during follow-
up. Furthermore, chance has no role to play in these results.
The outcomes of patients with low-flow high-gradient AS are
nearly identical to those of patients with normal-flow high-
gradient AS. When symptomatic, AVR is the only therapy that
can significantly improve functional capacity, symptoms, and
survival. Paradoxical low-flow low-gradient AS conveys the poor-
est outcome, even in asymptomatic patients. In this entity, though
the benefit of surgery is not proven, AVR may probably be
beneficial in selected patients. Of note, even if the data reported by
Kang et al. (3) are not applicable to this category, they suggest that
early AVR may improve survival. However, before considering
surgery, symptoms should be matched to the severity of AS.
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Reply
We thank Dr. Guntheroth for his interest in the paper by
Lancellotti et al. (1) and our editorial (2). He emphasizes the use
of mean gradient and aortic valve area, as opposed to peak
gradient, in managing aortic stenosis. The cited report from 1965
(3), which Dr. Guntheroth coauthored, allows a fascinating
glimpse into predigital cardiology using analog pressure tracings,
when determining a mean as opposed to a peak transaortic
gradient involved “special equipment” and considerable additional
work. The investigators demonstrated that spikes in left ventricular
pR
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gradients and that these peak gradients are related in a dependable
manner neither to the mean transaortic pressure gradient nor to
intraoperative assessment of the degree of stenosis. Moreover, in
their examples, peak gradients appear to have been measured as
peak-to-peak gradient, which may introduce further inaccuracies.
We entirely agree with Dr. Guntheroth that the mean gradient is
a more robust and appropriate measure of valvular obstruction than
the peak gradient, because it reflects obstruction over the whole of
systole instead of at 1 point in time only. The continuing
widespread use of peak gradients is a tradition, perhaps also
inspired by impressively high and round numbers (e.g., 100 mm Hg).
Valve area theoretically should be a still better parameter of
obstruction than gradients if there is a fixed valvular stenosis,
because it should be largely independent of stroke volume. How-
ever, unless measured directly by planimetry (which has its own
considerable practical problems [4]), both stroke volume and
pressure data are needed for its calculation (as well as taking into
account the difference between effective and anatomic valve area),
making it more vulnerable to measurement variation. For example,
in clinical practice, the calculation of valve area by the continuity
equation is considerably less reproducible than the mean (or peak)
gradient from a continuous-wave Doppler tracing. Thus, gradi-
ents, as well as valve area, will probably continue to be used in the
management of aortic stenosis.
It is important to note, however, that the report by Lancellotti
et al. (1) indicates that valve area1 cm2 alone is a relatively crude
redictor of prognosis in patients with asymptomatic aortic steno-sis and preserved ejection fraction and that using both gradient and
stroke volume together allows the identification of subgroups with
different prognoses.
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